TheraRadar
← Back
Data updated: Jul 17, 2026

HETERO USA INC

Pharma
Pharmaceuticals

HETERO USA INC is a pharmaceutical company with 0 FDA-approved products.

-
Since
0
Drugs
-
Trials
0
New Drugs (2yr)

HETERO USA INC's Key Drugs

HETERO USA INC's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).

No active drugs

HETERO USA INC's Recent FDA Approvals

New NDA/BLA approvals for HETERO USA INC over the last two years — novel drugs only, excluding generics and label supplements.

No recent approvals

HETERO USA INC's Therapeutic Areas

Disease areas where HETERO USA INC has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.

No indication data

HETERO USA INC Pipeline Snapshot

Active clinical trials for HETERO USA INC across all therapeutic areas, from ClinicalTrials.gov.

No active pipeline data available

Pro Intelligence Preview

Deep insights for investors and analysts

Revenue Insights

  • • Top drug revenue breakdown
  • • Drug-level revenue analysis

Trial Catalysts

  • • Active trial monitoring
  • • Phase 3 readout tracking

Patent Risk

  • • Patent expiration timeline
  • • Revenue at risk analysis

Compare Companies

  • • Side-by-side pipeline analysis
  • • Revenue & market share comparison
Unlock Full Intelligence

Revenue forecasts • Trial milestones • Patent risk modeling